Raydiant Oximetry Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
25
- Latest Deal Type
-
Series A3
- Latest Deal Amount
-
$1.84M
- Investors
-
36
Raydiant Oximetry General Information
Description
Developer of a non-invasive medical device designed to deliver healthy babies and prevent cesarean section issues. The company's device measures fetal oxygen levels during labor to facilitate improved outcomes for mothers and babies during childbirth and evaluates fetal oxygenation during labor, enabling clinicians to reduce the risk of birth injury and over-intervention as well as decrease healthcare costs and disparities.
Contact Information
Website
www.raydiantoximetry.comCorporate Office
- 2603 Camino Ramon
- Suite 423
- San Ramon, CA 94583
- United States
Corporate Office
- 2603 Camino Ramon
- Suite 423
- San Ramon, CA 94583
- United States
Raydiant Oximetry Timeline
Raydiant Oximetry Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 17. Later Stage VC (Series A3) | 11-Feb-2026 | $1.84M | Completed | Clinical Trials - Phase 2 | ||
| 16. Grant | 01-Nov-2024 | Completed | Clinical Trials - Phase 2 | |||
| 15. Grant | 24-Sep-2024 | Completed | Clinical Trials - Phase 2 | |||
| 14. Later Stage VC (Series B) | 07-Jun-2024 | Completed | Clinical Trials - Phase 2 | |||
| 13. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 12. Secondary Transaction - Private | Completed | Pre-Clinical Trials | ||||
| 11. Later Stage VC (Series A2) | 04-Nov-2021 | Completed | Pre-Clinical Trials | |||
| 10. Grant | 26-May-2021 | Completed | Pre-Clinical Trials | |||
| 9. Accelerator/Incubator | 08-Sep-2020 | $75K | $7.99M | Completed | Pre-Clinical Trials | |
| 8. Grant | 01-Jul-2020 | $1000K | $7.92M | Completed | Pre-Clinical Trials |
Raydiant Oximetry Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A3 | ||||||||
| Series A2 | ||||||||
| Series A1 | 1,971,090 | $0.000010 | $0.06 | $1.06 | $1.06 | 1x | $1.06 | 5.96% |
| Series A | 6,841,423 | $0.000010 | $0.06 | $0.93 | $0.93 | 1x | $0.93 | 20.68% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Raydiant Oximetry Comparisons
Industry
Financing
Details
Raydiant Oximetry Competitors (10)
One of Raydiant Oximetry’s 10 competitors is Noninvasix, a Venture Capital-Backed company based in Galveston, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Noninvasix | Venture Capital-Backed | Galveston, TX | ||||
| Osure Care | Accelerator/Incubator Backed | Vishakhapatnam, India | ||||
| Bloomlife | Venture Capital-Backed | San Francisco, CA | ||||
| Biotronik | Corporate Backed or Acquired | Berlin, Germany | ||||
| Luciole Medical | Venture Capital-Backed | Zurich, Switzerland |
Raydiant Oximetry Patents
Raydiant Oximetry Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026213427-A1 | Devices, systems, and methods of using effective optical attenuation coefficients to perform fetal oximetry calculations | Pending | 02-Apr-2025 | ||
| WO-2026183135-A1 | Systems, devices, and methods for determining fetal wellness using fetal ecg and fetal oximetry information | Pending | 25-Feb-2025 | ||
| EP-4836720-A1 | Systems, devices, and methods for detecting, measuring, and/or monitoring fetal heart rate and methods for using same | Pending | 06-Jan-2025 | ||
| WO-2026044152-A1 | Uterine drains, uterine drain systems, and methods for using same | Pending | 22-Aug-2024 | ||
| US-D1134835-S1 | Surgical drain | Active | 15-Apr-2024 |
Raydiant Oximetry Signals
Raydiant Oximetry Investors (36)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Gates Foundation | Not-For-Profit Venture Capital | |||
| Catalytic Impact Foundation | Not-For-Profit Venture Capital | Minority | ||
| Cross Border Impact Ventures | Impact Investing | Minority | ||
| Impact Assets | Impact Investing | Minority | ||
| March of Dimes | Corporation | Minority |
Raydiant Oximetry FAQs
-
When was Raydiant Oximetry founded?
Raydiant Oximetry was founded in 2016.
-
Where is Raydiant Oximetry headquartered?
Raydiant Oximetry is headquartered in San Ramon, CA.
-
What is the size of Raydiant Oximetry?
Raydiant Oximetry has 25 total employees.
-
What industry is Raydiant Oximetry in?
Raydiant Oximetry’s primary industry is Monitoring Equipment.
-
Is Raydiant Oximetry a private or public company?
Raydiant Oximetry is a Private company.
-
What is the current valuation of Raydiant Oximetry?
The current valuation of Raydiant Oximetry is .
-
What is Raydiant Oximetry’s current revenue?
The current revenue for Raydiant Oximetry is .
-
How much funding has Raydiant Oximetry raised over time?
Raydiant Oximetry has raised $22.3M.
-
Who are Raydiant Oximetry’s investors?
Gates Foundation, Catalytic Impact Foundation, Cross Border Impact Ventures, Impact Assets, and March of Dimes are 5 of 36 investors who have invested in Raydiant Oximetry.
-
Who are Raydiant Oximetry’s competitors?
Noninvasix, Osure Care, Bloomlife, Biotronik, and Luciole Medical are some of the 10 competitors of Raydiant Oximetry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process